SCHEMBL753062

SCHEMBL753062

C[C@@H](c1ccc(-c2ccc(C(=O)O)c(Cl)c2)cc1Cl)[C@](O)(c1ccc(=O)[nH]c1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.36
PRKAB2 O43741 4/20 0.35
PRKAG1 P54619 4/20 0.35
PRKAA2 P54646 4/20 0.35
PRKAA1 Q13131 4/20 0.35
PRKAG3 Q9UGI9 4/20 0.35
PRKAG2 Q9UGJ0 4/20 0.35
PRKAB1 Q9Y478 4/20 0.35
XDH P47989 1/20 0.35
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
PDE2A O00408 3/20 0.34
GAA P10253 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
AR P10275 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479995 1.00 PDK2 (0.36) PDK2PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL480080 0.93 PRKAB2 (0.34) PDK2PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL752284 0.93 PRKAB2 (0.34) PDK2PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL479836 0.93 GRIK1 (0.38) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL754464 0.93 GRIK1 (0.38) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL479731 0.87 RXRB (0.37) PDK2PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL480019 0.85 RXRA (0.40) PDE2ARXRARXRB
SCHEMBL754909 0.85 RXRA (0.40) PDE2ARXRARXRB
SCHEMBL15789769 0.85 PDE2A (0.33) AKR1C2PDE2AGAA
SCHEMBL15789713 0.85 GAA (0.33) PDE2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 PDK2 936/4885PRKAB2 3310/4885PRKAG1 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.